You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金達威(002626.SZ):DRB並未對NMN產品的實際效用進行過明確承諾、且已明確提示其效用未經過FDA評估
格隆匯 07-23 16:32

格隆匯 7 月 23日丨金達威(002626.SZ)發佈股票交易異常波動的公告稱,公司關注到多家相關媒體及其公眾號的報道,投資者也對公司在Doctor's Best(以下簡稱DRB)天貓旗艦店JD旗艦店(2020722日開放)正在預售的一NMN產品較為關注,現對相關事項的風險提示如下:

DRB並未對該產品的實際效用進行過明確承諾,且已明確提示該產品效用經過FDA的評估不用於診斷、治療、治癒或預防任何疾病。公司對DRB推出的NMN新產品市場前景並不確定,且未來可實現的銷售規模亦不確定,目前對公司的經營業績不會產生重大影響。敬請投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account